SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-040101
Filing Date
2019-08-14
Accepted
2019-08-14 16:31:57
Documents
3
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv527644_8k.htm 8-K 19911
2 EXHIBIT 99.1 tv527644_ex99-1.htm EX-99.1 105885
3 GRAPHIC image_001.jpg GRAPHIC 4571
  Complete submission text file 0001144204-19-040101.txt   133428
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 191026954
SIC: 2836 Biological Products, (No Diagnostic Substances)